Repligen
S&P 400
$165.18
+0.30%
Delayed · cached 15 min
Frequently asked questions
What sector does Repligen belong to?
Repligen operates in the Health Care sector, specifically the Biotechnology industry, and is listed on the US markets.
What is the current share price of RGEN?
As of the latest available quote, RGEN traded at $165.18. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of RGEN?
Repligen has a price-to-earnings (P/E) ratio of about 226.27. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of RGEN?
The market capitalisation of Repligen is approximately $9.39B.
Is Repligen profitable?
For its latest reported financial year, Repligen recorded a net profit margin of about 6.62%.
Does RGEN pay a dividend?
Repligen does not currently show a dividend yield in our data.
What is the return on equity (ROE) of RGEN?
Repligen has a return on equity (ROE) of about 2.32%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of RGEN?
Over the past 52 weeks, RGEN has traded between a low of $100.99 and a high of $188.73.
These answers are generated from reported financial data and live market figures, for educational and informational purposes only.